AUSTRALIAN Wool Innovation's research partner has made solid progress in the exploration of a new intradermal alternative to mulesing, with Cobbett Technologies exploring the use of Sodium Lauryl Sulphate as an intradermal alternative.
An AWI spokesperson confirmed this morning that the company was on target to approve funding for a second phase of trials that would involve a compound commonly used in low concentrations in toothpaste, shampoo and many household items.
"AWI and Cobbett are happy with progress and results are encouraging to date," the spokesperson said.
The spokesperson could not divulge detail on an expected timeframe of the trial.
Rural Press understands AWI invested $600,000 in phase one of the now completed intradermal trials.
During this phase the variables of pressure, concentrations, application pattern and equipment adjustments were explored and focused in on optimal settings.
It is understood phase two will focus on addressing variability of results between animals, fine tuning of application patterns over the tail, and efficacy requirements for registration of the compound through the Australian Pesticides and Veterinary Medicines Authority.
Phase two will also explore how the compound achieves its results of an increased bare area and the reduction in breech wrinkle.
Email a friend